| scholarly article | Q13442814 |
| P50 | author | Henk W. Berendse | Q64855307 |
| Odile A van den Heuvel | Q72932510 | ||
| P2093 | author name string | Jan Booij | |
| Chris Vriend | |||
| Afina W Lemstra | |||
| Jessica J van der Zande | |||
| Merijn Joling | |||
| P2860 | cites work | Imaging of the dopaminergic neurotransmission system using single-photon emission tomography and positron emission tomography in patients with parkinsonism. | Q48290148 |
| Analysis of Extrastriatal 123I-FP-CIT Binding Contributes to the Differential Diagnosis of Parkinsonian Diseases. | Q48426705 | ||
| Cognitive and behavioral assessment in the early stages of neurodegenerative extrapyramidal syndromes. | Q48458290 | ||
| Correlation between 123I-FP-CIT brain SPECT and parkinsonism in dementia with Lewy bodies: caveat for clinical use. | Q48494189 | ||
| Assessing the optimal time point for the measurement of extrastriatal serotonin transporter binding with 123I-FP-CIT SPECT in healthy, male subjects. | Q48495238 | ||
| Cognitive executive impairment and dopaminergic deficits in de novo Parkinson's disease. | Q48496079 | ||
| [123I]FP-CIT binds to the dopamine transporter as assessed by biodistribution studies in rats and SPECT studies in MPTP-lesioned monkeys. | Q48604652 | ||
| Pedunculopontine cholinergic cell loss in hallucinating Parkinson disease patients but not in dementia with Lewy bodies patients. | Q48874432 | ||
| SPECT imaging of dopamine transporters in human brain with iodine-123-fluoroalkyl analogs of beta-CIT. | Q48968515 | ||
| Optimizing patient care and research: the Amsterdam Dementia Cohort. | Q50712172 | ||
| Staging of brain pathology related to sporadic Parkinson's disease | Q28131702 | ||
| Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium | Q29614409 | ||
| Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases | Q29614910 | ||
| Cognitive and neuropsychiatric profile of the synucleinopathies: Parkinson disease, dementia with Lewy bodies, and multiple system atrophy | Q33917271 | ||
| Neuropsychiatric Symptoms in Parkinson's Disease Dementia Are More Similar to Alzheimer's Disease than Dementia with Lewy Bodies: A Case-Control Study | Q35996176 | ||
| Dystrophic serotonergic axons in neurodegenerative diseases. | Q36118481 | ||
| [(123)]FP-CIT SPECT scans initially rated as normal became abnormal over time in patients with probable dementia with Lewy bodies | Q36834554 | ||
| Dopamine transporter imaging with [(123)I]FP-CIT SPECT: potential effects of drugs | Q36984958 | ||
| Autopsy validation of 123I-FP-CIT dopaminergic neuroimaging for the diagnosis of DLB. | Q37610726 | ||
| The incidence and characteristics of Lewy bodies in idiopathic paralysis agitans (Parkinson's disease). | Q39407755 | ||
| Serotonin transporters in dopamine transporter imaging: a head-to-head comparison of dopamine transporter SPECT radioligands 123I-FP-CIT and 123I-PE2I. | Q39816943 | ||
| Selecting a Selective Serotonin Reuptake Inhibitor: Clinically Important Distinguishing Features | Q39853590 | ||
| The Lewy body variant of Alzheimer's disease: a clinical and pathologic entity | Q42479244 | ||
| Midbrain SERT in degenerative parkinsonisms: a 123I-FP-CIT SPECT study | Q42952850 | ||
| Staging of serotonergic dysfunction in Parkinson's disease: an in vivo 11C-DASB PET study | Q42994792 | ||
| Depressive symptoms in Parkinson's disease are related to reduced [123I]FP-CIT binding in the caudate nucleus | Q43833622 | ||
| European multicentre database of healthy controls for [123I]FP-CIT SPECT (ENC-DAT): age-related effects, gender differences and evaluation of different methods of analysis | Q43948177 | ||
| Striatal dopamine transporter in dementia with Lewy bodies and Parkinson disease: a comparison. | Q44891243 | ||
| Dopamine transporter loss visualized with FP-CIT SPECT in the differential diagnosis of dementia with Lewy bodies. | Q44946964 | ||
| Regional distribution of serotonin transporter protein in postmortem human brain: is the cerebellum a SERT-free brain region? | Q45274909 | ||
| Extrastriatal binding of [¹²³I]FP-CIT in the thalamus and pons: gender and age dependencies assessed in a European multicentre database of healthy controls. | Q45729007 | ||
| Progression of dopaminergic degeneration in dementia with Lewy bodies and Parkinson's disease with and without dementia assessed using 123I-FP-CIT SPECT. | Q46523791 | ||
| Serotonin transporter binding and anxiety symptoms in Parkinson's disease | Q47297132 | ||
| Rostral raphe involvement in Lewy body dementia and multiple system atrophy | Q48101201 | ||
| Striatal dopaminergic markers in dementia with Lewy bodies, Alzheimer's and Parkinson's diseases: rostrocaudal distribution | Q48147364 | ||
| Quantification of striatal dopamine transporters with 123I-FP-CIT SPECT is influenced by the selective serotonin reuptake inhibitor paroxetine: a double-blind, placebo-controlled, crossover study in healthy control subjects | Q48255848 | ||
| P921 | main subject | Parkinson's disease | Q11085 |
| dementia | Q83030 | ||
| P304 | page(s) | 130-136 | |
| P577 | publication date | 2018-04-06 | |
| P1433 | published in | NeuroImage: Clinical | Q22907265 |
| P1476 | title | Lower 123I-FP-CIT binding to the striatal dopamine transporter, but not to the extrastriatal serotonin transporter, in Parkinson's disease compared with dementia with Lewy bodies. | |
| P478 | volume | 19 |
| Q91608044 | Serotonergic deficits in dementia with Lewy bodies with concomitant Alzheimer's disease pathology: An 123I-FP-CIT SPECT study |
| Q64104625 | Striatal DAT and extrastriatal SERT binding in early-stage Parkinson's disease and dementia with Lewy bodies, compared with healthy controls: An I-FP-CIT SPECT study |
Search more.